Matthew Brook

20 papers receiving 2.6k citations

Peers

Matthew Brook
Comparison fields: 5 of 100
  • Cancer Research 636
  • Immunology 628
  • Molecular Biology 1.7k
  • Pharmacology 325
  • Oncology 494
Replace Jonathan L. E. Dean with:
Jonathan L. E. Dean United Kingdom
Arndt Schottelius Germany
Ping‐Hui Tseng Taiwan
Bartholomew J. Votta United States
Rudolf A. Rupec Germany
Nywana Sizemore United States
Elke Boone Belgium
Manfred Neumann Germany
Rebecca Chinery United Kingdom
Chang-Hoon Woo South Korea
Matthew Brook relative to Jonathan L. E. Dean United Kingdom Jonathan L. E. Dean's profile →
Citations per field
00.5×1.5×
Jonathan L. E. Dean · 1×
Citations per year

Countries citing papers authored by Matthew Brook

Since Specialization
Citations

This map shows the geographic impact of Matthew Brook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Brook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Brook more than expected).

Fields of papers citing papers by Matthew Brook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Brook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Brook. The network helps show where Matthew Brook may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew Brook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Brook Line = papers co-authored together Matthew Brook links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 201667
3 201516
4 201225
5 201236
6 201236
7 201140
8 201145
9 201035
10 201044
11 20102
12 200988
13 2006343
14 2006223
15 2004135
16 2001390
17 2001223
18 2000197
19 1999461
20 1998191

About Matthew Brook

Matthew Brook is a scholar working on Cancer Research, Biochemistry, Molecular Biology, Immunology and Pharmacology, having authored 20 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA Research and Splicing (12 papers), RNA modifications and cancer (4 papers), RNA regulation and disease (4 papers), NF-κB Signaling Pathways (4 papers), Immune Response and Inflammation (3 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer-related gene regulation (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Cancer Research (636 citations), Immunology (628 citations), Molecular Biology (1.7k citations), Pharmacology (325 citations) and Oncology (494 citations). Matthew Brook has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Andrew R. Clark, Jeremy Saklatvala, Jonathan L. E. Dean, Gareth Sully, Nicola K. Gray, Kamal R Mahtani, Marina Lasa, Achim D. Gruber, Edward Hitti and Danuta Radzioch. Their work appears in journals such as Molecular and Cellular Biology, Biochemical Society Transactions, Proceedings of the National Academy of Sciences, FEBS Letters and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026